Interestingly, we found that the IGF-Trap had superior therapeutic efficacy to an anti-IGF-IR antibody or IGF-binding protein-1 when used at similar or higher concentrations in a human breast cancer model and experimental murine colon cancer metastasis assays, respectively. This evidence concerns the gene IGF1 and colonic neoplasm.